Buyer for animal vaccine producer in Europe 

Company to buy

• Size: Small to mid-size business
• Revenue: 3 – 30 million EUR
• Target location: Europe
• CFIE PHB256

Overview of buyer for animal vaccine producer in Europe 

With a global footprint, this organization is dedicated to providing solutions for economically significant respiratory and enteric diseases in pigs and poultry. To this aim, their extensive knowledge and high-quality products significantly improve the health and welfare of these animals. The company’s commitment to customers is reflected in its provision of consistently high-quality products. Above all, they are supported by dedicated, customer-focused teams.

Profile of buyer for animal vaccine producer in Europe 

Overall, the company strives to offer scientifically proven, ethical solutions to optimize the health, productivity, and well-being of pigs and poultry. In particular, their vision emphasizes sustainability and collaboration with animal health professionals and livestock producers. Thus, aiming to enhance animal husbandry practices worldwide. Notably, they respect and invest in relationships, uphold high professional standards, and continuously seek innovation and improvement.

Activity and products of buyer for animal vaccine producer in Europe 

As an integrated solution provider, the company is actively pursuing the development of biological products. Chiefly, this is to complement its therapeutic offerings for key pathogens affecting pigs and poultry. Altogether, they hold marketing authorizations in over 70 countries. Primarily, by distributing their products through third-party distributors, subsidiaries, joint ventures, and direct sales to major integrators. Their flagship products include:

• Aivlosin/Valosin solutions: These proprietary, patented medications are effective against respiratory and enteric diseases in pigs and poultry. Designed as next-generation antibiotics, they align with current guidelines for responsible antimicrobial use and meet the needs of discerning consumers while offering economic benefits to producers. Available only through veterinary prescription.
• Parasite solutions: Under the brand name Ecomectin®, the company offers a range of products to treat internal and external parasites in cattle, sheep, and pigs, addressing various health issues caused by parasites.

Highlights of buyer for animal vaccine producer in Europe 

• Global presence: Operates in over 70 countries, with a robust distribution network that includes third-party distributors, subsidiaries, joint ventures, and direct sales to major integrators.
• Commitment to innovation: Actively developing biological products and novel therapeutic solutions, including a unique, long-acting injectable antibiotic (florfenicol) for pigs.
• Research collaborations: Partnering with research institutions to develop innovative vaccines for several significant diseases, including Marek’s disease virus, infectious bursal disease virus, Newcastle disease virus, infectious laryngotracheitis virus, and a novel approach for infectious bronchitis virus. Recently initiated a collaboration to develop novel vaccine approaches for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).
• Ethical and sustainable practices: Dedicated to providing ethical solutions that improve animal health and productivity, while also meeting sustainability goals and enhancing animal husbandry globally.
• Customer-focused approach: Committed to delivering high-quality products and building long-lasting, productive relationships with clients, both internally and externally.
• Continuous improvement: Embraces a culture of curiosity and continuous learning, constantly reviewing and improving products and practices to stay at the forefront of the industry.

Currently, the company is seeking to acquire a producer of animal vaccines in Europe. Essentially, aiming to expand its product offerings and enhance its capabilities in the animal health sector. This acquisition aligns with their mission to provide scientifically proven, ethical solutions that optimize animal health and productivity.

More information on this buyer for animal vaccine producer in Europe 

Please get in touch if you are interested in learning more about this buyer for animal vaccine producer in Europe . For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.